Robert Hennessey

Co-founder and Chairman of the Board. Mr. Hennessey was the former Chairman, President and CEO of Genome Therapeutics, previously known as Collaborative Research. He restructured Collaborative Research into a drug discovery and genomics Company (1993-2000) and increased the market cap of the company from $15MM (3/93) to a peak of $1.53 billion (3/2000). He was also on the Boards of Repligen Corporation and Penwest Pharmaceuticals for over 10 years. Mr. Hennessey worked with multiple clients in the biotech and pharma space from 1990 to 1993 as an independent consultant. Prior to consulting, he spent 10 years as a Senior Vice President of Corporate Development at Sterling Drug, Inc. and was responsible for centrally directed strategic planning, licensing, acquisitions, and venture investments worldwide. Mr. Hennessey has also worked at Abbott Laboratories as a Director for International Strategic Planning and Business Development, SmithKline and Merck Sharp & Dohme International.